Egis proposes Ft 120 dividend, unchanged from last year - extended
Egis Nyrt, the Hungarian drugmaker owned by France's Les Laboratoires Servier, proposed to pay Ft 120 dividend on its fiscal 2006 results.
Egis shareholders will vote on the dividend proposal at the Budapest-based company's January 24 meeting, Egis said in stock exchange statement published in the bourse's newsletter today. The AGM will vote on the company's 2005/2006 financial report, appointments and amendments to the company charter. Calculated with Hungarian Accounting Standards, Egis had unconsolidated pre-tax profits of Ft 15.8 billion in its 2005/2006 business year, up 23.2% from the previous year. Revenue was Ft 88.1 billion, up 20.7%, operating profits were Ft 13.7 billion, up 23.4%. Calculated with International Financial Reporting Standards (IFRS), Egis had unconsolidated net profit of Ft 87.4 billion in its 2005/2006 business year, 49.6% more than in the previous year. Revenue rose 20.3% to Ft 87.4 billion. (Bloomberg, Mti-Eco))
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.